These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1760809)

  • 1. Characterization of a monoclonal antibody directed against the epidermal growth factor receptor binding site.
    Pellegrini R; Centis F; Martignone S; Mastroianni A; Tagliabue E; Tosi E; Ménard S; Colnaghi MI
    Cancer Immunol Immunother; 1991; 34(1):37-42. PubMed ID: 1760809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual mode of action of a human anti-epidermal growth factor receptor monoclonal antibody for cancer therapy.
    Bleeker WK; Lammerts van Bueren JJ; van Ojik HH; Gerritsen AF; Pluyter M; Houtkamp M; Halk E; Goldstein J; Schuurman J; van Dijk MA; van de Winkel JG; Parren PW
    J Immunol; 2004 Oct; 173(7):4699-707. PubMed ID: 15383606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human epidermal growth factor (EGF) receptor sequence recognized by EGF competitive monoclonal antibodies. Evidence for the localization of the EGF-binding site.
    Wu DG; Wang LH; Sato GH; West KA; Harris WR; Crabb JW; Sato JD
    J Biol Chem; 1989 Oct; 264(29):17469-75. PubMed ID: 2477372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.
    Baselga J; Norton L; Masui H; Pandiella A; Coplan K; Miller WH; Mendelsohn J
    J Natl Cancer Inst; 1993 Aug; 85(16):1327-33. PubMed ID: 8340945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
    Fan Z; Masui H; Altas I; Mendelsohn J
    Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of two monoclonal antibodies against the COOH-terminal part of the human epidermal growth factor receptor and potential clinical use.
    Troalen F; Maudelondé T; Montcourrier P; Bohuon C; Delarue JC
    J Immunol Methods; 1991 Oct; 143(2):175-86. PubMed ID: 1719099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of antibody valency in EGF receptor modulation.
    Morelli D; Villa E; Tagliabue E; Perletti L; Villa ML; Ménard S; Balsari A; Colnaghi MI
    Scand J Immunol; 1994 May; 39(5):453-8. PubMed ID: 8191221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of human tumor xenografts with an indium-111-labeled anti-epidermal growth factor receptor monoclonal antibody.
    Goldenberg A; Masui H; Divgi C; Kamrath H; Pentlow K; Mendelsohn J
    J Natl Cancer Inst; 1989 Nov; 81(21):1616-25. PubMed ID: 2795690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of receptor density and cell shape on epidermal growth factor binding.
    Berkers JA; van Bergen en Henegouwen PP; Boonstra J
    J Recept Res; 1992; 12(1):71-100. PubMed ID: 1564701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-EGFR monoclonal antibodies which act as EGF, TGF alpha, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours.
    Modjtahedi H; Komurasaki T; Toyoda H; Dean C
    Int J Cancer; 1998 Jan; 75(2):310-6. PubMed ID: 9462724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor efficacy of an anti-epidermal-growth-factor-receptor monoclonal antibody and its F(ab')2 fragment against high- and low-EGFR-expressing carcinomas in nude mice.
    Tosi E; Valota O; Negri DR; Adobati E; Mazzoni A; Meazza R; Ferrini S; Colnaghi MI; Canevari S
    Int J Cancer; 1995 Sep; 62(5):643-50. PubMed ID: 7665239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation.
    Sunada H; Magun BE; Mendelsohn J; MacLeod CL
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3825-9. PubMed ID: 2424012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor (EGF) and monoclonal antibody to cell surface EGF receptor bind to the same chromatin receptor.
    Rakowicz-Szulczynska EM; Otwiaska D; Rodeck U; Koprowski H
    Arch Biochem Biophys; 1989 Feb; 268(2):456-64. PubMed ID: 2783644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice.
    Aboud-Pirak E; Hurwitz E; Pirak ME; Bellot F; Schlessinger J; Sela M
    J Natl Cancer Inst; 1988 Dec; 80(20):1605-11. PubMed ID: 3193478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a bifunctional monoclonal antibody directed against a tumor marker and doxorubicin on the growth of epidermoid vulvar carcinoma grafted in athymic mice.
    Morelli D; Ménard S; Pozzi B; Balsari A; Colnaghi MI
    Cell Biophys; 1994; 24-25():119-26. PubMed ID: 7736515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of anti-epidermal growth factor (EGF) receptor antibodies and an anti-EGF receptor recombinant-ricin A chain immunoconjugate on growth of human cells.
    Taetle R; Honeysett JM; Houston LL
    J Natl Cancer Inst; 1988 Sep; 80(13):1053-9. PubMed ID: 3261802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity.
    Gill GN; Kawamoto T; Cochet C; Le A; Sato JD; Masui H; McLeod C; Mendelsohn J
    J Biol Chem; 1984 Jun; 259(12):7755-60. PubMed ID: 6330079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy with antibodies to the EGF receptor.
    Dean C; Modjtahedi H; Eccles S; Box G; Styles J
    Int J Cancer Suppl; 1994; 8():103-7. PubMed ID: 8194887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical recognition of the epidermal growth factor receptor by the h-R3 antibody in the skin of experimental animals.
    Maceira M; Rengifo E; Cedeño M; Merino N; Casacó Parada A
    Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):360-3. PubMed ID: 15536338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-idiotypic response to antigrowth factor receptor monoclonal antibodies.
    Tosi E; Valota O; Canevari S; Adobati E; Casalini P; Perez P; Colnaghi MI
    Eur J Cancer; 1996 Mar; 32A(3):498-505. PubMed ID: 8814698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.